Susanne Rhoades
Associate Vice President, Diagnostic Development Eli Lilly
Seminars
Thursday 25th September 2025
Expanding Precision Medicine’s Reach: Driving Harmonized Commercialization of Drug-Diagnostics to Enable Timely, Adoptable Therapy Launch
Tuesday 23rd September 2025
Collaborating through Complexity: A Case Study in Global, Pan-Tumor CDx Development
11:30 am
- Explore insights from Eli Lilly & Company and Foundation Medicine’s partnership to develop a pan-tumor companion diagnostic for Retevmo
- Discover the power of expertise, collaboration, and creative validation strategies for overcoming complexities such as sample limitations and diverse global regulatory requirements
- Learn how the right partnership can accelerate patient access to therapy
Thursday 25th September 2025
Chair’s Opening Remarks
8:00 am
Thursday 25th September 2025
Chair’s Closing Remarks & End of 15th World Clinical Biomarkers & CDx Summit
2:50 pm
Tuesday 23rd September 2025
Panel Discussion: Assessing Biopharma Partnership Selection Strategies in Precision Medicine to Strengthen Strategic Partnerships & Accelerate Clinical Success
11:10 am
- What capabilities, compliance, or market experience drive appetite to collaborate with a particular vendor? And how do different pharma companies prioritize vendor selection considering these criteria?
- What is the role of cross-functional teams in efficient vendor evaluation across pharma organizations?
- What is the significance of global vendor footprint in the context of co-development and large scale manufacturing?
- How are testing decisions around centralized or decentralized testing determined in each market?
